# Related references



| exposure | category | consortium | id | pmid | population | priority | sample\_size | subcategory | year |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| Adiponectin \|\| id:1 | Risk factor | ADIPOGen | 1 | 22479202 | Mixed | 1 | 39883 | Protein | 2012 |
| Crohn's disease \|\| id:10 | Disease | IIBDGC | 10 | 23128233 | European | 1 | 30740 | Autoimmune / inflammatory | 2012 |
| Years of schooling \|\| id:1001 | Risk factor | SSGAC | 1001 | 27225129 | European | 1 | 293723 | Education | 2016 |
| Mean platelet volume \|\| id:1006 | Risk factor | HaemGen | 1006 | 22139419 | European | 1 | 66867 | Haemotological | 2011 |
| Neuroticism \|\| id:1007 | Risk factor | SSGAC | 1007 | 27089181 | European | 1 | 170911 | Personality | 2016 |
| Platelet count \|\| id:1008 | Risk factor | HaemGen | 1008 | 22139419 | European | 1 | 66867 | Haemotological | 2011 |
| C-reactive protein \|\| id:1015 | Risk factor | BioBank Japan Project | 1015 | 21196492 | Japanese | 1 | 10112 | Immune system | 2016 |
| Multiple sclerosis \|\| id:1024 | Disease | IMSGC | 1024 | 21833088 | European | 1 | 27098 | Autoimmune / inflammatory | 2011 |
| Multiple sclerosis \|\| id:1025 | Disease | IMSGC | 1025 | 24076602 | European | 1 | 38589 | Autoimmune / inflammatory | 2013 |
| Height \|\| id:1034 | Risk factor | EGG | 1034 | 23449627 | European | 1 | 13960 | Anthropometric | 2013 |
| Hippocampus volume \|\| id:1045 | Risk factor | ENIGMA | 1045 | 25607358 | European | 1 | 30717 | Psychiatric / neurological | 2015 |
| Putamen volume \|\| id:1047 | Risk factor | ENIGMA | 1047 | 25607358 | European | 1 | 30717 | Psychiatric / neurological | 2015 |
| Iron \|\| id:1049 | Risk factor | GIS | 1049 | 25352340 | European | 1 | 23986 | Metal | 2014 |
| Ferritin \|\| id:1050 | Risk factor | GIS | 1050 | 25352340 | European | 1 | 23986 | Metal | 2014 |
| Transferrin Saturation \|\| id:1051 | Risk factor | GIS | 1051 | 25352340 | European | 1 | 23986 | Metal | 2014 |
| Transferrin \|\| id:1052 | Risk factor | GIS | 1052 | 25352340 | European | 1 | 23986 | Metal | 2014 |
| Gout \|\| id:1054 | Disease | GUGC | 1054 | 23263486 | European | 1 | 69374 | Autoimmune / inflammatory | 2013 |
| Urate \|\| id:1055 | Risk factor | GUGC | 1055 | 23263486 | European | 1 | 110347 | Other | 2013 |
| Heart rate \|\| id:1056 | Risk factor | HRgene consortium | 1056 | 23583979 | Mixed | 1 | 92355 | Hemodynamic | 2013 |
| Celiac disease \|\| id:1058 | Disease | NA | 1058 | 22057235 | European | 1 | 24269 | Autoimmune / inflammatory | 2011 |
| Celiac disease \|\| id:1059 | Disease | NA | 1059 | 20190752 | European | 1 | 15283 | Autoimmune / inflammatory | 2010 |
| Celiac disease \|\| id:1060 | Disease | NA | 1060 | 20190752 | European | 1 | 11950 | Autoimmune / inflammatory | 2010 |
| Sitting height ratio \|\| id:1070 | Risk factor | NA | 1070 | 25865494 | European | 1 | 21590 | Anthropometric | 2015 |
| Copper \|\| id:1073 | Risk factor | NA | 1073 | 23720494 | European | 1 | 2603 | Metal | 2013 |
| Zinc \|\| id:1079 | Risk factor | NA | 1079 | 23720494 | European | 1 | 2603 | Metal | 2013 |
| Birth weight \|\| id:1083 | Risk factor | NA | 1083 | 27680694 | European | 1 | 143677 | Anthropometric | 2016 |
| Birth weight \|\| id:1084 | Risk factor | NA | 1084 | 27680694 | Mixed | 1 | 153781 | Anthropometric | 2016 |
| Amyotrophic lateral sclerosis \|\| id:1085 | Disease | Project MinE | 1085 | 27455348 | European | 1 | 36052 | Psychiatric / neurological | 2016 |
| Amyotrophic lateral sclerosis \|\| id:1086 | Disease | Project MinE | 1086 | 27455348 | European | 1 | 36052 | Psychiatric / neurological | 2016 |
| Chronotype \|\| id:1087 | Risk factor | UK Biobank | 1087 | 27494321 | European | 1 | 128266 | Sleeping | 2016 |
| Sleep duration \|\| id:1088 | Risk factor | UK Biobank | 1088 | 27494321 | European | 1 | 128266 | Sleeping | 2016 |
| Childhood obesity \|\| id:1096 | Risk factor | EGG | 1096 | 22484627 | European | 1 | 13848 | Anthropometric | 2012 |
| Crohn's disease \|\| id:11 | Disease | IIBDGC | 11 | 26192919 | East Asian | 1 | 5409 | Autoimmune / inflammatory | 2015 |
| Chronic kidney disease \|\| id:1102 | Disease | CKDGen | 1102 | 26831199 | Mixed | 1 | 117165 | Kidney | 2015 |
| Serum creatinine \(eGFRcrea\) \|\| id:1104 | Risk factor | CKDGen | 1104 | 26831199 | Mixed | 2 | 118460 | Kidney | 2015 |
| Serum creatinine \(eGFRcrea\) \|\| id:1105 | Risk factor | CKDGen | 1105 | 26831199 | Mixed | 1 | 133814 | Kidney | 2015 |
| Serum cystatin C \(eGFRcys\) \|\| id:1106 | Risk factor | CKDGen | 1106 | 26831199 | Mixed | 1 | 33152 | Kidney | 2015 |
| Primary sclerosing cholangitis  \|\| id:1112 | Disease | IPSCSG | 1112 | 27992413 | Mixed | 1 | 14890 | Autoimmune / inflammatory | 2017 |
| Gamma-linolenic acid \(18:3n6\) \|\| id:1139 | Risk factor | CHARGE | 1139 | 24823311 | European | 1 | 8631 | Fatty acid | 2014 |
| Dihomo-gamma-linolenic acid \(20:3n6\) \|\| id:1140 | Risk factor | CHARGE | 1140 | 24823311 | European | 1 | 8631 | Fatty acid | 2014 |
| Arachidonic acid \(20:4n6\) \|\| id:1141 | Risk factor | CHARGE | 1141 | 24823311 | European | 1 | 8631 | Fatty acid | 2014 |
| Linoleic acid \(18:2n6\) \|\| id:1142 | Risk factor | CHARGE | 1142 | 24823311 | European | 1 | 8631 | Fatty acid | 2014 |
| Docosapentaenoic acid \(22:5n3\) \|\| id:1144 | Risk factor | CHARGE | 1144 | 21829377 | European | 1 | 8866 | Fatty acid | 2011 |
| Eicosapentaenoic acid \(20:5n3\) \|\| id:1147 | Risk factor | CHARGE | 1147 | 21829377 | European | 1 | 8866 | Fatty acid | 2011 |
| cis-trans-18:2 \|\| id:1150 | Risk factor | CHARGE | 1150 | 25646338 | European | 1 | 8013 | Fatty acid | 2015 |
| palmitoleic acid \(16:1n7\) \|\| id:1156 | Risk factor | CHARGE | 1156 | 23362303 | European | 1 | 8961 | Fatty acid | 2013 |
| Stearic acid \(18:0\) plasma levels \|\| id:1158 | Risk factor | CHARGE | 1158 | 23362303 | European | 1 | 8961 | Fatty acid | 2013 |
| Crohn's disease \|\| id:12 | Disease | IIBDGC | 12 | 26192919 | European | 1 | 51874 | Autoimmune / inflammatory | 2015 |
| Body mass index \|\| id:2 | Risk factor | GIANT | 2 | 25673413 | Mixed | 1 | 339224 | Anthropometric | 2015 |
| Schizophrenia \|\| id:22 | Disease | PGC | 22 | 25056061 | Mixed | 1 | 82315 | Psychiatric / neurological | 2014 |
| Type 2 diabetes \|\| id:23 | Disease | DIAGRAM | 23 | 24509480 | Mixed | 1 | 110452 | Diabetes | 2014 |
| Type 2 diabetes \|\| id:24 | Disease | DIAGRAMplusMetabochip | 24 | 22885922 | Mixed | 3 | 149821 | Diabetes | 2012 |
| Type 2 diabetes \|\| id:25 | Disease | DIAGRAM | 25 | 26551672 | Mixed | 4 | 84780 | Diabetes | 2015 |
| Type 2 diabetes \|\| id:26 | Disease | DIAGRAM | 26 | 22885922 | European | 2 | 69033 | Diabetes | 2012 |
| Birth weight \|\| id:27 | Risk factor | EGG | 27 | 23202124 | European | 1 | 26836 | Anthropometric | 2013 |
| Haemoglobin concentration \|\| id:270 | Risk factor | HaemGen | 270 | 23222517 | Mixed | 1 | 71861 | Haemotological | 2012 |
| Mean cell haemoglobin \|\| id:271 | Risk factor | HaemGen | 271 | 23222517 | Mixed | 1 | 64731 | Haemotological | 2012 |
| Mean cell haemoglobin concentration \|\| id:272 | Risk factor | HaemGen | 272 | 23222517 | Mixed | 1 | 67852 | Haemotological | 2012 |
| Mean cell volume \|\| id:273 | Risk factor | HaemGen | 273 | 23222517 | Mixed | 1 | 69335 | Haemotological | 2012 |
| Packed cell volume \|\| id:274 | Risk factor | HaemGen | 274 | 23222517 | Mixed | 1 | 63511 | Haemotological | 2012 |
| Red blood cell count \|\| id:275 | Risk factor | HaemGen | 275 | 23222517 | Mixed | 1 | 66214 | Haemotological | 2012 |
| Celiac disease \|\| id:276 | Disease | NA | 276 | 20190752 | European | 1 | 15283 | Autoimmune / inflammatory | 2010 |
| Birth length \|\| id:29 | Risk factor | EGG | 29 | 25281659 | European | 1 | 28459 | Anthropometric | 2015 |
| Inflammatory bowel disease \|\| id:292 | Disease | IIBDGC | 292 | 23128233 | European | 1 | 75000 | Autoimmune / inflammatory | 2012 |
| Inflammatory bowel disease \|\| id:293 | Disease | IIBDGC | 293 | 26192919 | East Asian | 1 | 6543 | Autoimmune / inflammatory | 2015 |
| Inflammatory bowel disease \|\| id:294 | Disease | IIBDGC | 294 | 26192919 | European | 1 | 65642 | Autoimmune / inflammatory | 2015 |
| Alzheimer's disease \|\| id:297 | Disease | IGAP | 297 | 24162737 | European | 2 | 54162 | Psychiatric / neurological | 2013 |
| Alzheimer's disease \|\| id:298 | Disease | IGAP | 298 | 24162737 | European | 1 | 74046 | Psychiatric / neurological | 2013 |
| HDL cholesterol \|\| id:299 | Risk factor | GLGC | 299 | 24097068 | Mixed | 1 | 187167 | Lipid | 2013 |
| Crohn's disease \|\| id:30 | Disease | IIBDGC | 30 | 26192919 | European | 1 | 20883 | Autoimmune / inflammatory | 2015 |
| LDL cholesterol \|\| id:300 | Risk factor | GLGC | 300 | 24097068 | Mixed | 1 | 173082 | Lipid | 2013 |
| Total cholesterol \|\| id:301 | Risk factor | GLGC | 301 | 24097068 | Mixed | 1 | 187365 | Lipid | 2013 |
| Triglycerides \|\| id:302 | Risk factor | GLGC | 302 | 24097068 | Mixed | 1 | 177861 | Lipid | 2013 |
| Tryptophan \|\| id:304 | Metabolites | NA | 304 | 24816252 | European | 1 | 7804 | Amino acid | 2014 |
| Leucine \|\| id:306 | Metabolites | NA | 306 | 24816252 | European | 1 | 7799 | Amino acid | 2014 |
| Cholesterol \|\| id:307 | Metabolites | NA | 307 | 24816252 | European | 1 | 7813 | Lipid | 2014 |
| Inflammatory bowel disease \|\| id:31 | Disease | IIBDGC | 31 | 26192919 | European | 1 | 34652 | Autoimmune / inflammatory | 2015 |
| Uridine \|\| id:316 | Metabolites | NA | 316 | 24816252 | European | 1 | 7800 | Nucleotide | 2014 |
| Ulcerative colitis \|\| id:32 | Disease | IIBDGC | 32 | 26192919 | European | 1 | 27432 | Autoimmune / inflammatory | 2015 |
| Tyrosine \|\| id:325 | Metabolites | NA | 325 | 24816252 | European | 1 | 7807 | Amino acid | 2014 |
| Stearate \(18:0\) \|\| id:331 | Metabolites | NA | 331 | 24816252 | European | 1 | 7803 | Fatty acid | 2014 |
| 4-acetamidobutanoate \|\| id:339 | Metabolites | NA | 339 | 24816252 | European | 1 | 6930 | Amino acid | 2014 |
| Citrate \|\| id:341 | Metabolites | NA | 341 | 24816252 | European | 1 | 7813 | Energy | 2014 |
| Heptanoate \(7:0\) \|\| id:349 | Metabolites | NA | 349 | 24816252 | European | 1 | 7802 | Fatty acid | 2014 |
| Laurate \(12:0\) \|\| id:350 | Metabolites | NA | 350 | 24816252 | European | 1 | 7793 | Fatty acid | 2014 |
| Proline \|\| id:355 | Metabolites | NA | 355 | 24816252 | European | 1 | 7816 | Amino acid | 2014 |
| Citrulline \|\| id:356 | Metabolites | NA | 356 | 24816252 | European | 1 | 7773 | Amino acid | 2014 |
| Gamma-glutamylglutamine \|\| id:359 | Metabolites | NA | 359 | 24816252 | European | 1 | 7662 | Peptide | 2014 |
| Gamma-glutamyltyrosine \|\| id:360 | Metabolites | NA | 360 | 24816252 | European | 1 | 7468 | Peptide | 2014 |
| Betaine \|\| id:362 | Metabolites | NA | 362 | 24816252 | European | 1 | 7806 | Amino acid | 2014 |
| X-03094 \|\| id:373 | Metabolites | NA | 373 | 24816252 | European | 1 | 7804 | Unknown metabolite | 2014 |
| Kynurenine \|\| id:375 | Metabolites | NA | 375 | 24816252 | European | 1 | 7816 | Amino acid | 2014 |
| Acetylphosphate \|\| id:378 | Metabolites | NA | 378 | 24816252 | European | 1 | 7789 | Energy | 2014 |
| Carnitine \|\| id:379 | Metabolites | NA | 379 | 24816252 | European | 1 | 7797 | Lipid | 2014 |
| 3-methyl-2-oxovalerate \|\| id:383 | Metabolites | NA | 383 | 24816252 | European | 1 | 7779 | Amino acid | 2014 |
| X-18601 \|\| id:396 | Metabolites | NA | 396 | 24816252 | European | 1 | 7663 | Unknown metabolite | 2014 |
| Myo-inositol \|\| id:417 | Metabolites | NA | 417 | 24816252 | European | 1 | 7803 | Lipid | 2014 |
| 1,5-anhydroglucitol \(1,5-AG\) \|\| id:419 | Metabolites | NA | 419 | 24816252 | European | 1 | 7746 | Carbohydrate | 2014 |
| X-08402 \|\| id:426 | Metabolites | NA | 426 | 24816252 | European | 1 | 7726 | Unknown metabolite | 2014 |
| 2-hydroxyisobutyrate \|\| id:427 | Metabolites | NA | 427 | 24816252 | European | 1 | 6539 | Amino acid | 2014 |
| 4-methyl-2-oxopentanoate \|\| id:429 | Metabolites | NA | 429 | 24816252 | European | 1 | 7776 | Amino acid | 2014 |
| Levulinate \(4-oxovalerate\) \|\| id:433 | Metabolites | NA | 433 | 24816252 | European | 1 | 6982 | Amino acid | 2014 |
| X-08988 \|\| id:435 | Metabolites | NA | 435 | 24816252 | European | 1 | 7776 | Unknown metabolite | 2014 |
| Asthma \|\| id:44 | Disease | GABRIEL | 44 | 20860503 | European | 1 | 26475 | Autoimmune / inflammatory | 2007 |
| X-10510 \|\| id:444 | Metabolites | NA | 444 | 24816252 | European | 1 | 7792 | Unknown metabolite | 2014 |
| N-acetylglycine \|\| id:449 | Metabolites | NA | 449 | 24816252 | European | 1 | 7135 | Amino acid | 2014 |
| Androsterone sulfate \|\| id:460 | Metabolites | NA | 460 | 24816252 | European | 1 | 7785 | Lipid | 2014 |
| Acetylcarnitine \|\| id:463 | Metabolites | NA | 463 | 24816252 | European | 1 | 7805 | Lipid | 2014 |
| Serine \|\| id:464 | Metabolites | NA | 464 | 24816252 | European | 1 | 7796 | Amino acid | 2014 |
| Hexanoylcarnitine \|\| id:467 | Metabolites | NA | 467 | 24816252 | European | 1 | 7786 | Lipid | 2014 |
| Alanine \|\| id:469 | Metabolites | NA | 469 | 24816252 | European | 1 | 7788 | Amino acid | 2014 |
| 2-aminobutyrate \|\| id:471 | Metabolites | NA | 471 | 24816252 | European | 1 | 7814 | Amino acid | 2014 |
| Butyrylcarnitine \|\| id:476 | Metabolites | NA | 476 | 24816252 | European | 1 | 7796 | Lipid | 2014 |
| Dehydroisoandrosterone sulfate \(DHEA-S\) \|\| id:478 | Metabolites | NA | 478 | 24816252 | European | 1 | 7793 | Lipid | 2014 |
| Propionylcarnitine \|\| id:479 | Metabolites | NA | 479 | 24816252 | European | 1 | 7813 | Lipid | 2014 |
| Hip circumference \|\| id:48 | Risk factor | GIANT | 48 | 25673412 | Mixed | 1 | 224459 | Anthropometric | 2015 |
| Caprylate \(8:0\) \|\| id:481 | Metabolites | NA | 481 | 24816252 | European | 1 | 7802 | Fatty acid | 2014 |
| 10-undecenoate \(11:1n1\) \|\| id:482 | Metabolites | NA | 482 | 24816252 | European | 1 | 7806 | Fatty acid | 2014 |
| X-11204 \|\| id:484 | Metabolites | NA | 484 | 24816252 | European | 1 | 7799 | Unknown metabolite | 2014 |
| X-02269 \|\| id:485 | Metabolites | NA | 485 | 24816252 | European | 1 | 7701 | Unknown metabolite | 2014 |
| Hip circumference \|\| id:49 | Risk factor | GIANT | 49 | 25673412 | European | 2 | 213038 | Anthropometric | 2015 |
| X-11315 \|\| id:495 | Metabolites | NA | 495 | 24816252 | European | 1 | 7785 | Unknown metabolite | 2014 |
| 1-linoleoylglycerophosphoethanolamine\* \|\| id:497 | Metabolites | NA | 497 | 24816252 | European | 1 | 7817 | Lipid | 2014 |
| X-11327 \|\| id:498 | Metabolites | NA | 498 | 24816252 | European | 1 | 7671 | Unknown metabolite | 2014 |
| 3-dehydrocarnitine\* \|\| id:500 | Metabolites | NA | 500 | 24816252 | European | 1 | 7809 | Lipid | 2014 |
| Pyroglutamine\* \|\| id:501 | Metabolites | NA | 501 | 24816252 | European | 1 | 7800 | Amino acid | 2014 |
| X-11423--O-sulfo-L-tyrosine \|\| id:509 | Metabolites | NA | 509 | 24816252 | European | 1 | 7765 | Amino acid | 2014 |
| X-11440 \|\| id:513 | Metabolites | NA | 513 | 24816252 | European | 1 | 7686 | Unknown metabolite | 2014 |
| X-11445--5-alpha-pregnan-3beta,20alpha-disulfate \|\| id:517 | Metabolites | NA | 517 | 24816252 | European | 1 | 2570 | Lipid | 2014 |
| X-11469 \|\| id:519 | Metabolites | NA | 519 | 24816252 | European | 1 | 7779 | Unknown metabolite | 2014 |
| X-11491 \|\| id:524 | Metabolites | NA | 524 | 24816252 | European | 1 | 6584 | Unknown metabolite | 2014 |
| HWESASXX\* \|\| id:526 | Metabolites | NA | 526 | 24816252 | European | 1 | 7700 | Peptide | 2014 |
| X-11529 \|\| id:528 | Metabolites | NA | 528 | 24816252 | European | 1 | 6664 | Unknown metabolite | 2014 |
| X-11538 \|\| id:531 | Metabolites | NA | 531 | 24816252 | European | 1 | 7804 | Unknown metabolite | 2014 |
| X-11593--O-methylascorbate\* \|\| id:536 | Metabolites | NA | 536 | 24816252 | European | 1 | 7788 | Cofactors and vitamins | 2014 |
| ADSGEGDFXAEGGGVR\* \|\| id:539 | Metabolites | NA | 539 | 24816252 | European | 1 | 5588 | Peptide | 2014 |
| Hip circumference \|\| id:54 | Risk factor | GIANT | 54 | 25673412 | Mixed | 9 | 225487 | Anthropometric | 2015 |
| X-11787 \|\| id:541 | Metabolites | NA | 541 | 24816252 | European | 1 | 7811 | Unknown metabolite | 2014 |
| X-11792 \|\| id:542 | Metabolites | NA | 542 | 24816252 | European | 1 | 2442 | Unknown metabolite | 2014 |
| X-11793--oxidized bilirubin\* \|\| id:543 | Metabolites | NA | 543 | 24816252 | European | 1 | 7611 | Cofactors and vitamins | 2014 |
| Hip circumference \|\| id:55 | Risk factor | GIANT | 55 | 25673412 | European | 10 | 211114 | Anthropometric | 2015 |
| 1-arachidonoylglycerophosphocholine\* \|\| id:558 | Metabolites | NA | 558 | 24816252 | European | 1 | 7507 | Lipid | 2014 |
| X-11905 \|\| id:560 | Metabolites | NA | 560 | 24816252 | European | 1 | 4761 | Unknown metabolite | 2014 |
| X-12063 \|\| id:570 | Metabolites | NA | 570 | 24816252 | European | 1 | 7197 | Unknown metabolite | 2014 |
| Gamma-glutamylphenylalanine \|\| id:572 | Metabolites | NA | 572 | 24816252 | European | 1 | 7753 | Peptide | 2014 |
| Isobutyrylcarnitine \|\| id:573 | Metabolites | NA | 573 | 24816252 | European | 1 | 7812 | Amino acid | 2014 |
| Erythronate\* \|\| id:578 | Metabolites | NA | 578 | 24816252 | European | 1 | 7752 | Carbohydrate | 2014 |
| X-12092 \|\| id:580 | Metabolites | NA | 580 | 24816252 | European | 1 | 7500 | Unknown metabolite | 2014 |
| X-12188 \|\| id:587 | Metabolites | NA | 587 | 24816252 | European | 1 | 832 | Unknown metabolite | 2014 |
| X-12189 \|\| id:588 | Metabolites | NA | 588 | 24816252 | European | 1 | 481 | Unknown metabolite | 2014 |
| X-12244--N-acetylcarnosine \|\| id:596 | Metabolites | NA | 596 | 24816252 | European | 1 | 6608 | Peptide | 2014 |
| Coronary heart disease \|\| id:6 | Disease | C4D | 6 | 21378988 | Mixed | 3 | 30482 | Cardiovascular | 2011 |
| Waist circumference \|\| id:60 | Risk factor | GIANT | 60 | 25673412 | Mixed | 1 | 224459 | Anthropometric | 2015 |
| ADpSGEGDFXAEGGGVR\* \|\| id:601 | Metabolites | NA | 601 | 24816252 | European | 1 | 3939 | Peptide | 2014 |
| 1-eicosatrienoylglycerophosphocholine\* \|\| id:602 | Metabolites | NA | 602 | 24816252 | European | 1 | 7809 | Lipid | 2014 |
| Waist circumference \|\| id:61 | Risk factor | GIANT | 61 | 25673412 | European | 2 | 232101 | Anthropometric | 2015 |
| X-12456 \|\| id:613 | Metabolites | NA | 613 | 24816252 | European | 1 | 4774 | Unknown metabolite | 2014 |
| Octanoylcarnitine \|\| id:615 | Metabolites | NA | 615 | 24816252 | European | 1 | 7790 | Lipid | 2014 |
| Alpha-hydroxyisovalerate \|\| id:616 | Metabolites | NA | 616 | 24816252 | European | 1 | 7668 | Amino acid | 2014 |
| Decanoylcarnitine \|\| id:618 | Metabolites | NA | 618 | 24816252 | European | 1 | 7766 | Lipid | 2014 |
| Epiandrosterone sulfate \|\| id:627 | Metabolites | NA | 627 | 24816252 | European | 1 | 7769 | Lipid | 2014 |
| X-12510--2-aminooctanoic acid \|\| id:629 | Metabolites | NA | 629 | 24816252 | European | 1 | 7566 | Amino acid | 2014 |
| X-12524 \|\| id:630 | Metabolites | NA | 630 | 24816252 | European | 1 | 7809 | Unknown metabolite | 2014 |
| X-12556 \|\| id:633 | Metabolites | NA | 633 | 24816252 | European | 1 | 7483 | Unknown metabolite | 2014 |
| 1-arachidonoylglycerophosphoinositol\* \|\| id:634 | Metabolites | NA | 634 | 24816252 | European | 1 | 7797 | Lipid | 2014 |
| X-12644 \|\| id:636 | Metabolites | NA | 636 | 24816252 | European | 1 | 7795 | Unknown metabolite | 2014 |
| Asparagine \|\| id:638 | Metabolites | NA | 638 | 24816252 | European | 1 | 7761 | Amino acid | 2014 |
| X-12696 \|\| id:640 | Metabolites | NA | 640 | 24816252 | European | 1 | 7409 | Unknown metabolite | 2014 |
| X-12728 \|\| id:646 | Metabolites | NA | 646 | 24816252 | European | 1 | 537 | Unknown metabolite | 2014 |
| Isovalerylcarnitine \|\| id:652 | Metabolites | NA | 652 | 24816252 | European | 1 | 7789 | Amino acid | 2014 |
| Bradykinin, des-arg\(9\) \|\| id:656 | Metabolites | NA | 656 | 24816252 | European | 1 | 4570 | Peptide | 2014 |
| Waist circumference \|\| id:66 | Risk factor | GIANT | 66 | 25673412 | Mixed | 9 | 245746 | Anthropometric | 2015 |
| X-12798 \|\| id:661 | Metabolites | NA | 661 | 24816252 | European | 1 | 7552 | Unknown metabolite | 2014 |
| X-12844 \|\| id:665 | Metabolites | NA | 665 | 24816252 | European | 1 | 7768 | Unknown metabolite | 2014 |
| X-12850 \|\| id:667 | Metabolites | NA | 667 | 24816252 | European | 1 | 6251 | Unknown metabolite | 2014 |
| Waist circumference \|\| id:67 | Risk factor | GIANT | 67 | 25673412 | European | 10 | 231353 | Anthropometric | 2015 |
| X-12855 \|\| id:670 | Metabolites | NA | 670 | 24816252 | European | 1 | 5120 | Unknown metabolite | 2014 |
| X-13215 \|\| id:675 | Metabolites | NA | 675 | 24816252 | European | 1 | 6305 | Unknown metabolite | 2014 |
| N2,N2-dimethylguanosine \|\| id:679 | Metabolites | NA | 679 | 24816252 | European | 1 | 5228 | Nucleotide | 2014 |
| 1-arachidonoylglycerophosphoethanolamine\* \|\| id:682 | Metabolites | NA | 682 | 24816252 | European | 1 | 7798 | Lipid | 2014 |
| X-13429 \|\| id:683 | Metabolites | NA | 683 | 24816252 | European | 1 | 6344 | Unknown metabolite | 2014 |
| X-13431--nonanoylcarnitine\* \|\| id:684 | Metabolites | NA | 684 | 24816252 | European | 1 | 6591 | Lipid | 2014 |
| X-13435 \|\| id:685 | Metabolites | NA | 685 | 24816252 | European | 1 | 6970 | Unknown metabolite | 2014 |
| X-13496 \|\| id:691 | Metabolites | NA | 691 | 24816252 | European | 1 | 7656 | Unknown metabolite | 2014 |
| X-13548 \|\| id:693 | Metabolites | NA | 693 | 24816252 | European | 1 | 6022 | Unknown metabolite | 2014 |
| Hydroxyisovaleroyl carnitine \|\| id:698 | Metabolites | NA | 698 | 24816252 | European | 1 | 5588 | Amino acid | 2014 |
| Glutaroyl carnitine \|\| id:699 | Metabolites | NA | 699 | 24816252 | European | 1 | 7701 | Amino acid | 2014 |
| Coronary heart disease \|\| id:7 | Disease | CARDIoGRAMplusC4D | 7 | 26343387 | Mixed | 1 | 184305 | Cardiovascular | 2015 |
| 1-palmitoylglycerophosphoethanolamine \|\| id:707 | Metabolites | NA | 707 | 24816252 | European | 1 | 7763 | Lipid | 2014 |
| Tetradecanedioate \|\| id:709 | Metabolites | NA | 709 | 24816252 | European | 1 | 6046 | Lipid | 2014 |
| Hexadecanedioate \|\| id:711 | Metabolites | NA | 711 | 24816252 | European | 1 | 6887 | Lipid | 2014 |
| Dihomo-linolenate \(20:3n3 or n6\) \|\| id:712 | Metabolites | NA | 712 | 24816252 | European | 1 | 7805 | Fatty acid | 2014 |
| X-14189--leucylalanine \|\| id:719 | Metabolites | NA | 719 | 24816252 | European | 1 | 2745 | Peptide | 2014 |
| Waist-to-hip ratio \|\| id:72 | Risk factor | GIANT | 72 | 25673412 | Mixed | 1 | 224459 | Anthropometric | 2015 |
| X-14208--phenylalanylserine \|\| id:721 | Metabolites | NA | 721 | 24816252 | European | 1 | 2455 | Peptide | 2014 |
| X-14304--leucylalanine \|\| id:722 | Metabolites | NA | 722 | 24816252 | European | 1 | 2434 | Peptide | 2014 |
| X-14626 \|\| id:729 | Metabolites | NA | 729 | 24816252 | European | 1 | 6904 | Unknown metabolite | 2014 |
| Waist-to-hip ratio \|\| id:73 | Risk factor | GIANT | 73 | 25673412 | European | 2 | 212244 | Anthropometric | 2015 |
| Octadecanedioate \|\| id:735 | Metabolites | NA | 735 | 24816252 | European | 1 | 7300 | Lipid | 2014 |
| Succinylcarnitine \|\| id:742 | Metabolites | NA | 742 | 24816252 | European | 1 | 6948 | Energy | 2014 |
| 5alpha-androstan-3beta,17beta-diol disulfate \|\| id:746 | Metabolites | NA | 746 | 24816252 | European | 1 | 7345 | Lipid | 2014 |
| 4-androsten-3beta,17beta-diol disulfate 1\* \|\| id:747 | Metabolites | NA | 747 | 24816252 | European | 1 | 7804 | Lipid | 2014 |
| 4-androsten-3beta,17beta-diol disulfate 2\* \|\| id:748 | Metabolites | NA | 748 | 24816252 | European | 1 | 7776 | Lipid | 2014 |
| Palmitoyl sphingomyelin \|\| id:751 | Metabolites | NA | 751 | 24816252 | European | 1 | 7814 | Lipid | 2014 |
| Cis-4-decenoyl carnitine \|\| id:753 | Metabolites | NA | 753 | 24816252 | European | 1 | 7660 | Lipid | 2014 |
| Years of schooling \|\| id:755 | Risk factor | SSGAC | 755 | 25201988 | European | 1 | 106736 | Education | 2014 |
| Fasting glucose \|\| id:757 | Risk factor | MAGIC | 757 | 20081858 | European | 4 | 46186 | Glycemic | 2010 |
| HbA1C \|\| id:758 | Risk factor | MAGIC | 758 | 20858683 | European | 1 | 46368 | Glycemic | 2010 |
| Corrected insulin response \|\| id:761 | Risk factor | MAGIC | 761 | 24699409 | European | 1 | 5318 | Glycemic | 2014 |
| Fasting proinsulin \|\| id:769 | Risk factor | MAGIC | 769 | 20081858 | European | 1 | 10701 | Glycemic | 2011 |
| HOMA-B \|\| id:770 | Risk factor | MAGIC | 770 | 20081858 | European | 1 | 46186 | Glycemic | 2011 |
| Fasting glucose \|\| id:773 | Risk factor | MAGIC | 773 | 22581228 | European | 3 | 58074 | Glycemic | 2012 |
| Fasting insulin \|\| id:774 | Risk factor | MAGIC | 774 | 22581228 | European | 3 | 51750 | Glycemic | 2012 |
| Fasting insulin \|\| id:775 | Risk factor | MAGIC | 775 | 22581228 | European | 4 | 51750 | Glycemic | 2012 |
| 2hr glucose \|\| id:776 | Risk factor | MAGIC | 776 | 22885924 | European | 1 | 42854 | Glycemic | 2013 |
| Fasting glucose \|\| id:777 | Risk factor | MAGIC | 777 | 22885924 | European | 1 | 133010 | Glycemic | 2012 |
| Fasting insulin \|\| id:778 | Risk factor | MAGIC | 778 | 22885924 | European | 2 | 108557 | Glycemic | 2013 |
| Fasting insulin \|\| id:779 | Risk factor | MAGIC | 779 | 22885924 | European | 1 | 108557 | Glycemic | 2013 |
| Waist-to-hip ratio \|\| id:78 | Risk factor | GIANT | 78 | 25673412 | Mixed | 9 | 224452 | Anthropometric | 2015 |
| HDL cholesterol \|\| id:780 | Risk factor | GLGC | 780 | 24097068 | Mixed | 2 | 92860 | Lipid | 2013 |
| LDL cholesterol \|\| id:781 | Risk factor | GLGC | 781 | 24097068 | Mixed | 2 | 83198 | Lipid | 2013 |
| Total cholesterol \|\| id:782 | Risk factor | GLGC | 782 | 24097068 | Mixed | 2 | 92260 | Lipid | 2013 |
| Triglycerides \|\| id:783 | Risk factor | GLGC | 783 | 24097068 | Mixed | 2 | 86852 | Lipid | 2013 |
| Urate \|\| id:789 | Risk factor | GUGC | 789 | 25811787 | European | 1 | 14504 | Other | 2015 |
| Waist-to-hip ratio \|\| id:79 | Risk factor | GIANT | 79 | 25673412 | European | 10 | 210082 | Anthropometric | 2015 |
| Urate \|\| id:792 | Risk factor | GUGC | 792 | 25811787 | European | 1 | 17078 | Other | 2015 |
| Urate \|\| id:795 | Risk factor | GUGC | 795 | 25811787 | European | 1 | 9445 | Other | 2015 |
| Myocardial infarction \|\| id:798 | Disease | CARDIoGRAMplusC4D | 798 | 26343387 | Mixed | 1 | 171875 | Cardiovascular | 2015 |
| Coronary heart disease \|\| id:8 | Disease | CARDIoGRAM | 8 | 21378990 | European | 2 | 86995 | Cardiovascular | 2011 |
| Bipolar disorder \|\| id:800 | Disease | PGC | 800 | 21926972 | European | 2 | 16731 | Psychiatric / neurological | 2011 |
| Bipolar disorder \|\| id:801 | Disease | PGC | 801 | 21926972 | European | 1 | 16731 | Psychiatric / neurological | 2011 |
| PGC cross-disorder traits \|\| id:803 | Disease | PGC | 803 | 23453885 | European | 1 | 61220 | Psychiatric / neurological | 2013 |
| Parkinson's disease \|\| id:812 | Disease | NA | 812 | 19915575 | European | 2 | 5691 | Psychiatric / neurological | 2009 |
| Systemic lupus erythematosus \|\| id:815 | Disease | NA | 815 | 18204098 | European | 1 | 3094 | Autoimmune / inflammatory | 2008 |
| Neuroblastoma \|\| id:816 | Disease | NA | 816 | 23222812 | European | 1 | 4881 | Cancer | 2013 |
| Rheumatoid arthritis \|\| id:831 | Disease | NA | 831 | 24390342 | East Asian | 1 | 22515 | Autoimmune / inflammatory | 2014 |
| Rheumatoid arthritis \|\| id:832 | Disease | NA | 832 | 24390342 | European | 1 | 58284 | Autoimmune / inflammatory | 2014 |
| Rheumatoid arthritis \|\| id:833 | Disease | NA | 833 | 24390342 | Mixed | 1 | 80799 | Autoimmune / inflammatory | 2014 |
| Rheumatoid arthritis \|\| id:834 | Disease | NA | 834 | 20453842 | European | 2 | 25708 | Autoimmune / inflammatory | 2010 |
| Body mass index \|\| id:835 | Risk factor | GIANT | 835 | 25673413 | European | 3 | 322154 | Anthropometric | 2015 |
| College completion \|\| id:836 | Risk factor | SSGAC | 836 | 23722424 | European | 1 | 95427 | Education | 2013 |
| Years of schooling \|\| id:837 | Risk factor | SSGAC | 837 | 23722424 | European | 1 | 101069 | Education | 2013 |
| Alanine \|\| id:840 | Metabolites | NA | 840 | 27005778 | European | 1 | 24796 | Amino acid | 2016 |
| Albumin \|\| id:841 | Metabolites | NA | 841 | 27005778 | European | 1 | 18960 | Protein | 2016 |
| Apolipoprotein A-I \|\| id:842 | Metabolites | NA | 842 | 27005778 | European | 1 | 20687 | Protein | 2016 |
| Apolipoprotein B \|\| id:843 | Metabolites | NA | 843 | 27005778 | European | 1 | 20690 | Protein | 2016 |
| Ratio of bisallylic groups to double bonds \|\| id:844 | Metabolites | NA | 844 | 27005778 | European | 1 | 13524 | Metabolites ratio | 2016 |
| Ratio of bisallylic groups to total fatty acids \|\| id:845 | Metabolites | NA | 845 | 27005778 | European | 1 | 13171 | Fatty acid | 2016 |
| Average number of methylene groups per double bond \|\| id:847 | Metabolites | NA | 847 | 27005778 | European | 1 | 13532 | Metabolites ratio | 2016 |
| Average number of methylene groups in a fatty acid chain \|\| id:848 | Metabolites | NA | 848 | 27005778 | European | 1 | 19021 | Fatty acid | 2016 |
| Citrate \|\| id:849 | Metabolites | NA | 849 | 27005778 | European | 1 | 24770 | Energy | 2016 |
| Extreme body mass index \|\| id:85 | Risk factor | GIANT | 85 | 23563607 | European | 1 | 16068 | Anthropometric | 2013 |
| Creatinine \|\| id:850 | Metabolites | NA | 850 | 27005778 | European | 1 | 24810 | Amino acid | 2016 |
| Average number of double bonds in a fatty acid chain \|\| id:851 | Metabolites | NA | 851 | 27005778 | European | 1 | 15728 | Fatty acid | 2016 |
| 22:6, docosahexaenoic acid \|\| id:852 | Metabolites | NA | 852 | 27005778 | European | 1 | 13499 | Fatty acid | 2016 |
| Free cholesterol to esterified cholesterol ratio \|\| id:853 | Metabolites | NA | 853 | 27005778 | European | 1 | 13497 | Lipid | 2016 |
| Omega-3 fatty acids \|\| id:855 | Metabolites | NA | 855 | 27005778 | European | 1 | 13544 | Fatty acid | 2016 |
| Omega-6 fatty acids \|\| id:856 | Metabolites | NA | 856 | 27005778 | European | 1 | 13506 | Fatty acid | 2016 |
| Omega-9 and saturated fatty acids \|\| id:857 | Metabolites | NA | 857 | 27005778 | European | 1 | 13506 | Fatty acid | 2016 |
| Free cholesterol \|\| id:858 | Metabolites | NA | 858 | 27005778 | European | 1 | 13497 | Lipid | 2016 |
| Glucose \|\| id:859 | Metabolites | NA | 859 | 27005778 | European | 1 | 24679 | Carbohydrate | 2016 |
| Extreme height \|\| id:86 | Risk factor | GIANT | 86 | 23563607 | European | 1 | 16196 | Anthropometric | 2013 |
| Glutamine \|\| id:860 | Metabolites | NA | 860 | 27005778 | European | 1 | 24462 | Amino acid | 2016 |
| Glycoproteins \|\| id:862 | Metabolites | NA | 862 | 27005778 | European | 1 | 18734 | Protein | 2016 |
| Glycoprotein acetyls \|\| id:863 | Metabolites | NA | 863 | 27005778 | European | 1 | 19270 | Protein | 2016 |
| Total cholesterol in HDL \|\| id:864 | Metabolites | NA | 864 | 27005778 | European | 1 | 21555 | Lipid | 2016 |
| Mean diameter for HDL particles \|\| id:865 | Metabolites | NA | 865 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Histidine \|\| id:866 | Metabolites | NA | 866 | 27005778 | European | 1 | 19244 | Amino acid | 2016 |
| Total cholesterol in IDL \|\| id:867 | Metabolites | NA | 867 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Free cholesterol in IDL \|\| id:868 | Metabolites | NA | 868 | 27005778 | European | 1 | 21559 | Lipid | 2016 |
| Total lipids in IDL \|\| id:869 | Metabolites | NA | 869 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Extreme waist-to-hip ratio \|\| id:87 | Risk factor | GIANT | 87 | 23563607 | European | 1 | 10255 | Anthropometric | 2013 |
| Concentration of IDL particles \|\| id:870 | Metabolites | NA | 870 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Phospholipids in IDL \|\| id:871 | Metabolites | NA | 871 | 27005778 | European | 1 | 21559 | Lipid | 2016 |
| Triglycerides in IDL \|\| id:872 | Metabolites | NA | 872 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Total cholesterol in large HDL \|\| id:874 | Metabolites | NA | 874 | 27005778 | European | 1 | 21558 | Lipid | 2016 |
| Cholesterol esters in large HDL \|\| id:875 | Metabolites | NA | 875 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Free cholesterol in large HDL \|\| id:876 | Metabolites | NA | 876 | 27005778 | European | 1 | 21559 | Lipid | 2016 |
| Total lipids in large HDL \|\| id:877 | Metabolites | NA | 877 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Concentration of large HDL particles \|\| id:878 | Metabolites | NA | 878 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Phospholipids in large HDL \|\| id:879 | Metabolites | NA | 879 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Total cholesterol in large LDL \|\| id:880 | Metabolites | NA | 880 | 27005778 | European | 1 | 21552 | Lipid | 2016 |
| Cholesterol esters in large VLDL \|\| id:881 | Metabolites | NA | 881 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Free cholesterol in large LDL \|\| id:882 | Metabolites | NA | 882 | 27005778 | European | 1 | 21555 | Lipid | 2016 |
| Total lipids in large LDL \|\| id:883 | Metabolites | NA | 883 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Concentration of large LDL particles \|\| id:884 | Metabolites | NA | 884 | 27005778 | European | 1 | 19273 | Lipid | 2016 |
| Phospholipids in large LDL \|\| id:885 | Metabolites | NA | 885 | 27005778 | European | 1 | 21550 | Lipid | 2016 |
| Total cholesterol in large VLDL \|\| id:886 | Metabolites | NA | 886 | 27005778 | European | 1 | 21235 | Lipid | 2016 |
| Cholesterol esters in large VLDL \|\| id:887 | Metabolites | NA | 887 | 27005778 | European | 1 | 18960 | Lipid | 2016 |
| Free cholesterol in large VLDL \|\| id:888 | Metabolites | NA | 888 | 27005778 | European | 1 | 21238 | Lipid | 2016 |
| Total lipids in large VLDL \|\| id:889 | Metabolites | NA | 889 | 27005778 | European | 1 | 18960 | Lipid | 2016 |
| Height \|\| id:89 | Risk factor | GIANT | 89 | 25282103 | European | 1 | 253288 | Anthropometric | 2014 |
| Concentration of large VLDL particles \|\| id:890 | Metabolites | NA | 890 | 27005778 | European | 1 | 18960 | Lipid | 2016 |
| Phospholipids in large VLDL \|\| id:891 | Metabolites | NA | 891 | 27005778 | European | 1 | 21239 | Lipid | 2016 |
| Triglycerides in large VLDL \|\| id:892 | Metabolites | NA | 892 | 27005778 | European | 1 | 21239 | Lipid | 2016 |
| 18:2, linoleic acid \(LA\) \|\| id:893 | Metabolites | NA | 893 | 27005778 | European | 1 | 13527 | Fatty acid | 2016 |
| Body fat \|\| id:999 | Risk factor | NA | 999 | 26833246 | European | 1 | 100716 | Anthropometric | 2016 |

